Company · CIK 0001759425 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Mirum Pharmaceuticals, Inc. · MIRM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 SForm 4 → | Sep 15, 4:10 pm EDT | Eric BjerkholtCHIEF FINANCIAL OFFICER | 9,943 | $98.37 | $978,093 | 44,745 | −18.2% | |
| Sep 11, 2026 MForm 4 → | Sep 15, 4:10 pm EDT | Eric BjerkholtCHIEF FINANCIAL OFFICER | 18,333 | — | — | 54,688 | — | |
| Sep 2, 2026 SForm 4 → | Sep 3, 6:54 pm EDT | Jolanda HoweSVP, GLOBAL CONTROLLER | 658 | $100.00 | $65,800 | 616 | −51.6% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 6:52 pm EDT | Christopher PeetzCHIEF EXECUTIVE OFFICER, Director | 30,000 | $98.68 | $2,960,401 | 194,440 | −13.4% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 6:52 pm EDT | Christopher PeetzCHIEF EXECUTIVE OFFICER, Director | 30,000 | $2.94 | $88,080 | 224,440 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 MForm 4 → | Sep 15, 4:10 pm EDT | Eric BjerkholtCHIEF FINANCIAL OFFICER | 18,333 | — | — | 0 | — | |
| Sep 1, 2026 MForm 4 → | Sep 3, 6:52 pm EDT | Christopher PeetzCHIEF EXECUTIVE OFFICER, Director | 30,000 | — | — | 58,487 | — | 10b5-1 |